<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39383996</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1701-2163</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</Title><ISOAbbreviation>J Obstet Gynaecol Can</ISOAbbreviation></Journal><ArticleTitle>Racial disparities in parturient urine drug screening at a Texas level IV maternal care center: a single-center retrospective study.</ArticleTitle><Pagination><StartPage>102679</StartPage><MedlinePgn>102679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jogc.2024.102679</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1701-2163(24)00502-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We hypothesized that Black or African American (hereby referred to as Black) and Hispanic patients would have higher rates of urine drug screening (UDS) during pregnancy compared to White or Caucasian (herby referred to as White) patients at our hospital.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients who delivered at our hospital between 1 December 2020 and 31 May 2021 and between 1 December 2022 and 31 May 2023, and who were Black, Hispanic, or White were included in the final analysis. We performed separate bivariate analyses comparing White patients to either Black patients or Hispanic patients. We performed a multivariate logistic regression including variables of interest designed to predict risk factors for UDS during pregnancy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">457, 813, and 1252 patients identified as Black, Hispanic, and White, respectively. 187 (40.9%) Black patients had UDS during pregnancy compared to 265 (21.2%) White patients (P &lt; 0.001). 258 (31.7%) Hispanic patients had UDS during pregnancy, which was also statistically different compared to White patients (P &lt; 0.001). A multivariate logistic regression found that identification as Black was independently associated with UDS during pregnancy (adjusted odds ratio [aOR] 1.871; 95% CI 1.382, 2.534; P &lt; 0.001); identification as Hispanic was not independently associated (aOR 1.177; 95% CI 0.900, 1.538; P = 0.234); and that patients who delivered after the COVID-19 pandemic were less likely to receive UDS (aOR 0.783; 95% CI 0.621, 0.987; P = 0.039).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Identification as Black and delivery during the COVID-19 pandemic were independently associated with increased adjusted odds of UDS during pregnancy at our hospital.</AbstractText><AbstractText Label="OBJECTIF" NlmCategory="OBJECTIVE">Nous avons émis l'hypothèse que le taux de dépistage toxicologique urinaire (DTU) pendant la grossesse serait plus élevé chez les patientes noires ou afro-américaines (ci-après désignées comme patientes noires) et les patientes hispaniques que chez les patientes blanches ou caucasiennes (ci-après désignées comme patientes blanches) dans notre hôpital. MéTHODES: Les patientes noires, hispaniques ou blanches qui ont accouché dans notre hôpital entre le 1 décembre 2020 et le 31 mai 2021 ou entre le 1 décembre 2022 et le 31 mai 2023 ont été incluses dans l'analyse finale. Nous avons réalisé des analyses bivariées distinctes comparant les patientes blanches aux patientes noires ou hispaniques. Nous avons utilisé la régression logistique multivariée avec des variables d'intérêt pour prédire les facteurs de risque du DTU pendant la grossesse. RéSULTATS: Nous avons répertorié 457, 813 et 1252 patientes noires, hispaniques et blanches, respectivement. Parmi elles, 187 patientes noires et 265 patientes blanches ont subi un DTU pendant la grossesse (40,9 % p r/à 21,2 %; P &lt; 0,001). Quant aux patientes hispaniques, 258 ont subi un DTU pendant la grossesse, pour un taux de 31,7 %, ce qui illustre aussi une différence statistiquement significative par comparaison avec les patientes blanches (P &lt; 0,001). Une analyse de régression logistique multivariée a révélé que l'identification comme patiente noire était associée de manière indépendante au DTU pendant la grossesse (rapport de cotes ajusté [RCa] : 1,871; IC à 95 % : 1,382-2,534; P &lt; 0,001); que l'identification comme patiente hispanique n'était pas associée de manière indépendante au DTU (RCa : 1,177; IC à 95 % : 0,900-1,538; P = 0,234); et que les patientes qui ont accouché après la pandémie de COVID-19 étaient moins susceptibles de subir un DTU (RCa : 0,783; IC à 95 % : 0,621-0,987; P = 0,039).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dans notre hôpital, l'identification comme patiente noire et l'accouchement pendant la pandémie de COVID-19 ont été associés de manière indépendante à l'augmentation du risque ajusté de DTU pendant la grossesse.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Izekor</LastName><ForeName>Ivie</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Texas A&amp;M School of Medicine, College Station, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindheim</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Baylor Scott &amp; White Medical Center-Temple, Temple, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrig</LastName><ForeName>Jessica C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Baylor Scott &amp; White Medical Center-Temple, Temple, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofkamp</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Baylor Scott &amp; White Medical Center-Temple, Temple, TX. Electronic address: Michael.Hofkamp@bswhealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Obstet Gynaecol Can</MedlineTA><NlmUniqueID>101126664</NlmUniqueID><ISSNLinking>1701-2163</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disparities</Keyword><Keyword MajorTopicYN="N">detection</Keyword><Keyword MajorTopicYN="N">healthcare</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">racial groups</Keyword><Keyword MajorTopicYN="N">substance abuse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39383996</ArticleId><ArticleId IdType="doi">10.1016/j.jogc.2024.102679</ArticleId><ArticleId IdType="pii">S1701-2163(24)00502-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle>